Securities code: Jiangsu Chinagreen Biological Technology Co.Ltd(300970) securities abbreviation: Jiangsu Chinagreen Biological Technology Co.Ltd(300970) Announcement No.: 2022014 Jiangsu Chinagreen Biological Technology Co.Ltd(300970)
Announcement on 2021 profit distribution plan
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) (hereinafter referred to as “the company”) held the 12th meeting of the 4th board of directors and the 12th meeting of the 4th board of supervisors on April 8, 2022. The proposal on profit distribution plan in 2021 was deliberated and adopted respectively. This proposal needs to be submitted to the general meeting of shareholders of the company for deliberation. The details are hereby announced as follows:
1、 2021 profit distribution plan
According to the audit of Zhitong Certified Public Accountants (special general partnership), the net profit attributable to the shareholders of the listed company in the consolidated statements of the company in 2021 is 1550457194 yuan, and the net profit of the parent company in 2021 is -487753521 yuan. As of December 31, 2021, the company’s profit distribution at the end of the consolidated statement period was 45062087146 yuan, of which the undistributed profit of the parent company was 6025694500 yuan.
Taking into account the company’s daily operation and long-term development capital needs, the company has formulated the profit distribution plan for 2021 as follows: no cash dividend, no bonus shares, and no capital reserve converted into share capital. The profit distribution plan needs to be submitted to the general meeting of shareholders of the company for deliberation.
2、 Reasons for non distribution in 2021
The company implements a continuous and stable profit distribution policy. The profit distribution of the company attaches importance to the reasonable return to investors and takes into account the sustainable development of the company. In view of the profit distribution in 2020 implemented by the company in July 2021, the company distributed cash dividends of RMB 5.20 (including tax) for every 10 shares to all shareholders based on the total share capital of 58350000 shares, with a total cash dividend of RMB 3034200000 (including tax), and the remaining undistributed profits are retained in the next year; At the same time, the capital reserve is used to increase 10 shares for every 10 shares to all shareholders, with a total of 58350000 shares. After the increase, the total share capital of the company is increased to 11670000 shares. According to the actual operating performance of the company in 2021 and the capital demand of normal operation in 2022, comprehensively considering the company’s strategic development plan and the current macroeconomic environment, in order to ensure the stability of the company’s production and operation, enhance the ability to resist risks, realize the sustainable, stable and healthy development of the company and better safeguard the long-term interests of all shareholders, the company decides not to distribute cash dividends and bonus shares in 2021, Capital reserve shall not be converted into share capital.
3、 Purpose and plan of undistributed profits of the company
In order to meet the capital needs of the company’s daily operation and long-term development, and provide reliable guarantee for the smooth implementation of the company’s medium and long-term development strategy and sustainable and healthy development, it is decided that the company plans not to distribute cash dividends, bonus shares, convert capital reserve into share capital, and carry forward undistributed profits to the next year in 2021. In the future, the company will always pay attention to the return to investors in the form of cash dividends. In strict accordance with the provisions of relevant laws and regulations and the articles of association, the company will comprehensively consider various factors related to profit distribution, actively implement the company’s profit distribution system from the perspective of conducive to the development of the company and the return of investors, and share the achievements of the company’s development with investors.
4、 Opinions of independent directors
After verification, we believe that the 2021 profit distribution plan proposed by the board of directors of the company, which does not distribute cash dividends, bonus shares or convert capital reserve into share capital, is in line with the actual situation of the company and relevant regulations. The profit distribution plan is legal, compliant and reasonable, and there is no damage to the rights and interests of minority shareholders, Conducive to the long-term development of the company. Therefore, we unanimously agree to the proposal on the profit distribution plan for 2021 and agree to submit the matter to the general meeting of shareholders of the company for deliberation.
5、 Opinions of the board of supervisors
On April 8, 2022, the 12th meeting of the Fourth Board of supervisors of the company deliberated and adopted the proposal on profit distribution plan for 2021. The board of supervisors believes that the profit distribution plan for 2021 drawn up by the board of directors of the company complies with the relevant provisions of the articles of association and the actual situation of the company, is conducive to the sustainable, stable and healthy development of the company, has fulfilled the necessary approval procedures, and complies with the relevant laws and regulations such as the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies Regulations, normative documents and the articles of association. The board of supervisors agreed to submit the matter to the general meeting of shareholders for deliberation.
6、 Documents for future reference
1. Resolutions of the 12th meeting of the 4th board of directors;
2. Resolutions of the 12th meeting of the 4th board of supervisors;
3. Independent opinions of independent directors on matters related to the 12th meeting of the Fourth Board of directors.
It is hereby announced.
Jiangsu Chinagreen Biological Technology Co.Ltd(300970) board of directors April 8, 2022
